In 2025, eligible pregnant women will be able to receive the respiratory syncytial virus (rsv) vaccine for free under the national immunisation program (nip). This fact sheet provides answers to frequently asked questions that consumers may have on the maternal rsv vaccine and the rsv immunisation product. The rsv vaccine and the rsv monoclonal antibody contain different ingredients and work in different ways to offer protection against serious illness caused by rsv.
Rsv is a leading cause of hospitalisation in. There have been almost 50,000 cases of rsv recorded this year, but only a select group can access the free vaccine, with other vulnerable australians needing to fork out hundreds of dollars. The rsv vaccine can protect against respiratory syncytial virus infections, especially in infants and people at high risk.
Respiratory syncytial virus (rsv) is a highly contagious respiratory virus. A single dose of rsv vaccine is recommended for all adults aged ≥75 years. Respiratory syncytial virus (rsv) is a common virus that can infect people of all ages. Rsv hospitalisation rates increase with age, and people aged ≥75 years are likely to have the greatest benefit from.
Respiratory syncytial virus (rsv) causes respiratory infections. Additional vaccine information for detailed advice on vaccine dosage, administration, contraindications and precautions, and variations from product information, please visit the. Rsv vaccination is especially important in pregnancy the maternal rsv vaccine, abrysvo®, helps to protect your newborn baby against rsv. Find out more about the symptoms and how to protect.
The rsv vaccine and the rsv immunisation product contain different ingredients and work in different ways to offer protection against serious illness caused by rsv. Rsv often spreads through respiratory droplets. Find out if your baby can get the free immunisation. Rsv mostly affects young children, but adults can also get sick.